Genomics

Dataset Information

0

Gene expression of SARS-CoV-2-infected Vero E6 cells with remdesivir treatment


ABSTRACT: RNA sequencing was performed on control and SARS-CoV-2 infected Vero E6 cells, with or without remdesivir treatment to study the biological changes after SARS-CoV-2 infection and to evaluate the effectiveness of remdesivir on the gene expression level. 500,000 Vero E6 cells were seeded in 6-well plates. The following day, the cell medium was replaced with fresh medium supplemented with either DMSO or 1 µM remdesivir, and cells were either mock-infected or infected with SARS-CoV-2 USA-WA1/2020 (MOI=0.3), with three replicates per experimental condition. Cells were harvested 24 hours after infection, and total RNA was extracted using the Qiagen® RNeasy® Plus Mini Kit. The quality of the extracted RNA was assessed with the Agilent® 2100 Bioanalyzer. Libraries were prepared from total RNA following ribosome RNA depletion using standard protocol according to Illumina®. Total RNA sequencing was then performed on the Illumina® NextSeq system; 150bp paired-end runs were performed and 100 million raw reads per sample were generated.

ORGANISM(S): Chlorocebus sabaeus

PROVIDER: GSE165955 | GEO | 2021/02/02

REPOSITORIES: GEO

Similar Datasets

2020-07-08 | GSE153940 | GEO
2021-03-23 | GSE169370 | GEO
2015-11-19 | E-GEOD-56193 | biostudies-arrayexpress
| PRJNA698644 | ENA
2021-04-16 | GSE169158 | GEO
2022-10-08 | GSE189920 | GEO
2020-11-21 | GSE161881 | GEO
2021-07-29 | PXD021403 | Pride
2021-07-29 | PXD021154 | Pride
2023-08-04 | GSE227528 | GEO